Page last updated: 2024-09-05

sb 203580 and sulindac sulfone

sb 203580 has been researched along with sulindac sulfone in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (sulindac sulfone)	Trials (sulindac sulfone)	Recent Studies (post-2010) (sulindac sulfone)
3,489	4	1,137	171	21	35

Protein Interaction Comparison

Protein	Taxonomy	sb 203580 (IC50)	sulindac sulfone (IC50)
Endothelin-1 receptor	Homo sapiens (human)		9.853

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lee, E; Lee, YJ; Lim, SJ	1

Other Studies

1 other study(ies) available for sb 203580 and sulindac sulfone

Article	Year
p38MAPK inhibitor SB203580 sensitizes human SNU-C4 colon cancer cells to exisulind-induced apoptosis. Oncology reports, 2006, Volume: 16, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Colonic Neoplasms; Flavonoids; HCT116 Cells; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Sulindac	2006

Article

Year

p38MAPK inhibitor SB203580 sensitizes human SNU-C4 colon cancer cells to exisulind-induced apoptosis.

Oncology reports, 2006, Volume: 16, Issue:5

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Colonic Neoplasms; Flavonoids; HCT116 Cells; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Sulindac

2006